Funded Tech Companies

Neurocentrx Pharma

Operating out of Edinburgh, Scotland, Neurocentrx Pharma has funding from private investors.

Company Overview

Company Name
Neurocentrx Pharma
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
Level 5, 9 Haymarket Square
Edinburgh, Scotland, EH3 8RY
UK
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
Neurocentrx is a clinical-stage biopharmaceutical company developing the world's first abuse-deterrent, immediate-release oral ketamine therapy designed for both in-clinic and at-home care settings. Headquartered in Edinburgh, Scotland, with global research collaborations and operations in Australia and the United States, our mission is to transform how care is delivered for people suffering from treatment-resistant mood disorders.
Profile
Neurocentrx Pharma LinkedIn Company Profile
Social Media
Neurocentrx Pharma Company Twitter Account
Company News
Neurocentrx Pharma News
Facebook
Neurocentrx Pharma on Facebook
YouTube
Neurocentrx Pharma on YouTube
Last Transaction
9/23/2025

Financing History

Date
Type
Amount
Venture Equity
$5,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Carmel Reilly
  Carmel Reilly LinkedIn Profile  Carmel Reilly Twitter Account  Carmel Reilly News  Carmel Reilly on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    neurocare | Neuroclues

     

    Share this article

     


    About Our Venture Capital Database

    This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary